NNNN
Anbio Biotechnology Class A Ordinary Shares
NASDAQ · Healthcare · Medical - Instruments & Supplies · DE
$6.47
−2.05%Institutional positioning
13F filings over the trailing two quarters
New 3Increased 3Reduced 0Sold out 8
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | Unchanged | 25,763 | May 15, 2026 |
| BNP PARIBAS ARBITRAGE, SNC | Increased | 10,400 | May 12, 2026 |
| MORGAN STANLEY | Increased | 7,338 | May 15, 2026 |
| UBS GROUP AG | Increased | 6,339 | May 5, 2026 |
| EVERSOURCE WEALTH ADVISORS, LLC | New Position | 266 | May 18, 2026 |
| WELLS FARGO & COMPANY/MN | Unchanged | 100 | Jul 8, 2026 |
| BARE FINANCIAL SERVICES, INC | New Position | 15 | May 14, 2026 |
| RONALD BLUE TRUST, INC. | New Position | 5 | Apr 20, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Sold Out | 0 | May 15, 2026 |
| EverSource Wealth Advisors, LLC | Sold Out | 0 | May 18, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | Sold Out | 0 | May 12, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
| Blue Trust, Inc. | Sold Out | 0 | Apr 20, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 15, 2026 |
| WELLS FARGO & COMPANY/MN | Sold Out | 0 | Jul 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings